Compare HGV & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HGV | MMED |
|---|---|---|
| Founded | 1992 | 1983 |
| Country | United States | United States |
| Employees | N/A | 2800 |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.3B |
| IPO Year | 2017 | 2026 |
| Metric | HGV | MMED |
|---|---|---|
| Price | $48.00 | $16.01 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $52.13 | $22.56 |
| AVG Volume (30 Days) | 1.1M | ★ 1.1M |
| Earning Date | 04-30-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.78 | N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | ★ $5,047,000,000.00 | N/A |
| Revenue This Year | $25.30 | $15.99 |
| Revenue Next Year | $1.98 | $10.00 |
| P/E Ratio | $62.43 | ★ N/A |
| Revenue Growth | ★ 1.33 | N/A |
| 52 Week Low | $36.79 | $10.65 |
| 52 Week High | $55.40 | $17.86 |
| Indicator | HGV | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 41.34 | 60.01 |
| Support Level | $48.03 | $14.70 |
| Resistance Level | $49.77 | N/A |
| Average True Range (ATR) | 1.57 | 0.87 |
| MACD | -0.36 | 0.04 |
| Stochastic Oscillator | 4.70 | 57.65 |
Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts and timeshare plans under the Hilton Grand Vacations brand. The company operates in two segments: Real estate sales and financing, and Resort operations and club management. The Real estate sales and financing segment generates revenue from VOI sales and consumer financing, including interest income from loans to members. The Resort operations and club management segment generates revenue from resort management services, club membership fees, and rental of available inventory. The majority of the company's revenue is earned through the Real estate sales and financing segment.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.